Literature DB >> 26188647

The Levels of Tau Isoforms Containing Exon-2 and Exon-10 Segments Increased in the Cerebrospinal Fluids of the Patients with Sporadic Creutzfeldt-Jakob Disease.

Cao Chen1, Wei Zhou1, Yan Lv1, Qi Shi1, Jing Wang1, Kang Xiao1, Li-Na Chen1, Bao-Yun Zhang1, Xiao-Ping Dong2,3.   

Abstract

The alteration of protein tau in the cerebrospinal fluid (CSF) of Creutzfeldt-Jakob disease (CJD) has been widely evaluated, possessing a significant diagnostic value for CJD. With the biotin-labeled tau-exon-specific mAbs, direct ELISA methods were established and the levels of tau isoforms containing exon-2 and exon-10 segments in CSF of the patients with various human prion diseases and in brain tissues of scrapie-infected animals were evaluated. The results showed that the levels of tau, especially containing four repeats in microtubule binding domain, were increased in the CSF samples of the patients with sporadic CJD (sCJD). Using the unlabeled (cold) mixed exon-specific mAbs, a competitive tau ELISA was conducted based on a commercial tau kit. It revealed that the majority of the increased tau in the CSF of sCJD cases was derived from the tau isoforms with exon-2 and exon-10 segments. Increases of CSF tau isoforms with exon-2 and exon-10 segments were also observed in the patients of E200K and T188K genetic CJD (gCJD), but not in the cases of fatal familiar insomnia (FFI). The increasing levels of tau isoforms with exon-2 and exon-10 segments in the group of sCJD correlated well with the positive 14-3-3 in CSF. Additionally, the similar alterative profiles of tau isoforms with exon-2 and exon-10 segments were also observed in the brain tissues of scrapie-infected rodents and a sCJD patient. Our data here propose the tau isoforms with exon-2 and exon-10 segments increase in CSF of sCJD and some types of gCJD, which may help to understand the physiological metabolism and pathological significance of various tau isoforms in the pathogenesis of prion diseases.

Entities:  

Keywords:  CSF; ELISA; Prion diseases; Tau isoform; sCJD

Mesh:

Substances:

Year:  2015        PMID: 26188647     DOI: 10.1007/s12035-015-9348-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  35 in total

1.  Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.

Authors:  T Arai; K Ikeda; H Akiyama; Y Shikamoto; K Tsuchiya; S Yagishita; T Beach; J Rogers; C Schwab; P L McGeer
Journal:  Acta Neuropathol       Date:  2001-02       Impact factor: 17.088

Review 2.  Mutations causing neurodegenerative tauopathies.

Authors:  Michel Goedert; Ross Jakes
Journal:  Biochim Biophys Acta       Date:  2005-01-03

3.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

Authors:  M Hong; V Zhukareva; V Vogelsberg-Ragaglia; Z Wszolek; L Reed; B I Miller; D H Geschwind; T D Bird; D McKeel; A Goate; J C Morris; K C Wilhelmsen; G D Schellenberg; J Q Trojanowski; V M Lee
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

4.  Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.

Authors:  Victoria Zhukareva; Sonali Joyce; Teresa Schuck; Vivianna Van Deerlin; Howard Hurtig; Roger Albin; Sid Gilman; Steven Chin; Bruce Miller; John Q Trojanowski; Virginia M-Y Lee
Journal:  Ann Neurol       Date:  2006-09       Impact factor: 10.422

5.  The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.

Authors:  Catherine Pennington; Gurjit Chohan; Jan Mackenzie; Mary Andrews; Robert Will; Richard Knight; Alison Green
Journal:  Neurosci Lett       Date:  2009-03-05       Impact factor: 3.046

6.  Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies.

Authors:  Jian-Ming Chen; Chen Gao; Qi Shi; Bing Shan; Yan-Jun Lei; Chen-Fang Dong; Run An; Gui-Rong Wang; Bao-Yun Zhang; Jun Han; Xiao-Ping Dong
Journal:  Arch Virol       Date:  2008-04-11       Impact factor: 2.574

7.  Tauopathy in human and experimental variant Creutzfeldt-Jakob disease.

Authors:  G Giaccone; M Mangieri; R Capobianco; L Limido; J J Hauw; S Haïk; P Fociani; O Bugiani; F Tagliavini
Journal:  Neurobiol Aging       Date:  2007-06-08       Impact factor: 4.673

8.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

9.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

10.  Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Authors:  M Goedert; M G Spillantini; M C Potier; J Ulrich; R A Crowther
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  2 in total

1.  Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.

Authors:  Cao Chen; Xiao-Feng Xu; Ren-Qing Zhang; Yue Ma; Yan Lv; Jian-Le Li; Qiang Shi; Kang Xiao; Jing Sun; Xiao-Dong Yang; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2017-09-03       Impact factor: 3.931

2.  Low activity of complement in the cerebrospinal fluid of the patients with various prion diseases.

Authors:  Cao Chen; Yan Lv; Qi Shi; Wei Zhou; Kang Xiao; Jing Sun; Xiao-Dong Yang; Xiao-Ping Dong
Journal:  Infect Dis Poverty       Date:  2016-05-03       Impact factor: 4.520

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.